Internal and Emergency Medicine

Prescription of SGLT-2 inhibitors alone or in combination with RAS-inhibitors in patients with diabetes mellitus and comorbid cardiovascular disease, chronic kidney disease or cardiorenal disease: a real-world evidence study from the REPOSI registry

Study in peoplePopulations

The paper

Paolo Lido, Sara Ratti, Chiara Ronchetti, Show 426 more authorsAndrea Grillo

Italian Medicines Agency

Internal and Emergency Medicine, 25 Aug 2026

doi.org/10.1007/s11739-026-04495-8PubMed 42642609